An automated tool for detecting medication overuse based on the electronic health records

Pharmacoepidemiology and Drug Safety

Volumn 22, Issue 2, 2013, Pages 183-189

  Salmasian, Hojjat ^a   Freedberg, Daniel E ^b   Abrams, Julian A ^b   Friedman, Carol ^a  

^a Columbia University ^*  (United States)

^b Department of Medicine   (United States)

Author keywords

Drug utilization; Electronic health records; Indications; Natural language processing; Overuse; Pharmacoepidemiology; Proton pump inhibitors

Indexed keywords

ESOMEPRAZOLE; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ACCURACY; AGED; ARTICLE; AUTOMATION; BARRETT ESOPHAGUS; DIGESTIVE SYSTEM ULCER; DRUG ABUSE; DRUG INDICATION; DUODENAL ULCER BLEEDING; DUODENITIS; DUODENOGASTRIC REFLUX; DUODENUM ULCER; DYSPEPSIA; ELECTRONIC MEDICAL RECORD; EROSIVE GASTRITIS; ESOPHAGITIS; ESOPHAGUS ULCER; ESOPHAGUS VARICES BLEEDING; FEMALE; GASTRIC ULCER BLEEDING; GASTROENTERITIS; GASTROENTEROLOGY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTION; HEMORRHAGIC GASTRITIS; HOSPITAL PATIENT; HUMAN; INTERRATER RELIABILITY; KNOWLEDGE BASE; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH HEMORRHAGE; STOMACH PERFORATION; STOMACH ULCER; STRESS ULCER; UPPER GASTROINTESTINAL BLEEDING;

EID: 84873468828     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3387     Document Type: Article

References (54)

1. National Institute for Health Care Management Research and Education Foundation. Prescription Drug Expenditures in 2001: Another Year of Escalating Costs. May 2002. http://www.nihcm.org/pdf/spending2001.pdf (accessed 25 August 2012).
2. Ballard DJ. Indicators to improve clinical quality across an integrated health care system. Int J Qual Health Care 2003; 15(Suppl 1): i13-i23.
3. Hurtado MP, Swift EK, Corrigan JM (eds.). Envisioning the national health care quality report. Institute of Medicine: Washington, DC, 2001.
4. Naunton M, Peterson GM, Bleasel MD. Overuse of proton pump inhibitors. J Clin Pharm Ther 2000; 25: 333-340.
5. Conti R, Busch AB, Cutler DM. Overuse of antidepressants in a nationally representative adult patient population in 2005. Psychiatr Serv 2011; 62: 720-726.
6. Autier P, Creplet J, Vansant G, et al. The impact of reimbursement criteria on the appropriateness of "statin" prescribing. Eur J Cardiovasc Prev Rehabil 2003; 10: 456-462.
7. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008: 135: 1383-1391, 1391.e1-5.
8. de Carle DJ. Gastro-oesophageal reflux disease. Medical J Aust 1998; 169: 549-554.
9. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression. Gastroenterology 1990; 99: 345-351.
10. Hollingworth S, Duncan EL, Martin JH. Marked increase in proton pump inhibitors use in Australia. Pharmacoepidemiol Drug Saf 2010; 19: 1019-1024.
11. Bashford JN, Norwood J, Chapman SR. Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database. Br Med J 1998; 317: 452-456.
12. IMS Health Miads. Top therapeutic classes by US sales. April 6, 2010. http://www.imshealth.com/deployedfiles/imshealth/Global/Content/StaticFile/Top_Line_Data/Top%20Therapy%20Classes%20by%20U.S.Sales.pdf (accessed 25 August 2012)
13. IMS Health Midas. Top 25 drugs in the US market by sales. February 23, 2012. http://www.imshealth.com/deployedfiles/ims/Global/Content/Corporate/Press%20Room/Top-Line%20Market%20Data%20&%20Trends/2011%20Top-line%20Market%20Data/Top_Products_by_Sales.pdf (accessed 25 August 2012).
14. Pillans PI, Kubler PA, Radford JM, et al. Concordance between use of proton pump inhibitors and prescribing guidelines. Med J Aust 172: 16-18.
15. Nardino RJ, Vender RJ, Herbert PN. Overuse of acid-suppressive therapy in hospitalized patients. Am J Gastroenterol 2000; 95: 3118-3122.
16. Lucas LM, Gerrity MS, Anderson T. A practice-based approach for converting from proton pump inhibitors to less costly therapy. Eff Clin Pract 2001; 4: 263-270.
17. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. Br Med J 2008; 336: 2-3.
18. Dial S, Alrasadi K, Manoukian C, et al. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004; 171: 33-38.
19. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. NEJM 2011; 365: 1693-1703.
20. Stevens V, Dumyati G, Brown J, et al. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Pharmacoepidemiol Drug Saf 2011; 20: 1035-1042.
21. Valuck RJ, Ruscin JM. A case-control study on adverse effects: H2 blocker or proton pump inhibitor use and risk of vitamin B12 deficiency in older adults. J Clin Epidemiol 2004; 57: 422-428.
22. Yang YX, Lewis JD, Epstein S, et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296: 2947-2953.
23. Corley DA, Kubo A, Zhao W, et al. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology 2010; 139: 93-101.
24. Chiu HF, Huang YW, Chang CC, et al. Use of proton pump inhibitors increased the risk of hip fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf 2010; 19: 1131-1136.
25. Sharma VR, Brannon MA, Carloss EA. Effect of omeprazole on oral iron replacement in patients with iron deficiency anemia. South Med J 2004; 97: 887-889.
26. Leonard CE, Freeman CP, Newcomb CW, et al. Proton pump inhibitors and traditional nonsteroidal anti-inflammatory drugs and the risk of acute interstitial nephritis and acute kidney injury. Pharmacoepidemiol Drug Saf 2012. doi: 10.1002/pds.3329
27. Härmark L, van der Wiel HE, de Groot MCH, et al. Proton pump inhibitor-induced acute interstitial nephritis. Brit J Clin Pharmacol 2007; 64: 819-823.
28. García Rodríguez LA, Lagergren J, Lindblad M. Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK. Gut 2006; 55: 1538-1544.
29. Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci 2011; 56: 931-950.
30. Laheij RJ, Sturkenboom MC, Hassing RJ, et al. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292: 1955-1960.
31. Ho PM, Maddox TM, Wang L, et al. Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA 2009; 301: 937-944.
32. Stockl KM, Zakharyan A, Harada AS, et al. Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor. Arch Intern Med 2010; 170: 704-710.
33. Gerhard T. Clopidogrel and proton pump inhibitors: a clinically meaningful interaction? Pharmacoepidemiol Drug Saf 2011; 20: 214-218.
34. Van Soest EM, Siersema PD, Dieleman JP, et al. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006; 24: 377-385.
35. FDA. FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associated with stomach acid drugs known as proton pump inhibitors (PPIs). http://www.fda.gov/drugs/drugsafety/ucm290510.htm (accessed 25 August 2012).
36. Batuwitage BT, Kingham JG, Morgan NE, et al. Inappropriate prescribing of proton pump inhibitors in primary care. Postgrad Med J 2007; 83: 66-68.
37. Choudhry MN, Soran H, Ziglam HM. Overuse and inappropriate prescribing of proton pump inhibitors in patients with Clostridium difficile-associated disease. QJM 2008; 101: 445-448.
38. Kaplan DM. Clear writing, clear thinking and the disappearing art of the problem list. J Hosp Med 2007; 2: 199-202.
39. Szeto HC, Coleman RK, Gholami P, et al. Accuracy of computerized outpatient diagnoses in a Veterans Affairs general medicine clinic. Am J Manag Care 2002; 8: 37-43.
40. Tang PC, LaRosa MP, Gorden SM. Use of computer-based records, completeness of documentation, and appropriateness of documented clinical decisions. J Am Mde infor Assoc 1999; 6: 245-251.
41. Wright A, Maloney FL, Feblowitz JC. Clinician attitudes toward and use of electronic problem lists: a thematic analysis. BMC Med Inform Decis Mak 2001; 11: 36.
42. Hripcsak G, Friedman C, Alderson PO, et al. Unlocking clinical data from narrative reports: a study of natural language processing. Ann Int Med 1995; 122: 681-688.
43. Demner-Fushman D, Chapman WW, McDonald CJ. What can natural language processing do for clinical decision support? J Biomed Inform 2009; 42: 760-772.
44. Murff HJ, FitzHenry F, Matheny ME, et al. Automated identification of postoperative complications within an electronic medical record using natural language processing. JAMA 2011; 306: 848-855.
45. Meystre SM, Haug PJ. Randomized controlled trial of an automated problem list with improved sensitivity. Int J Med Inform 2008; 77: 602-612.
46. Solti I, Aaronson B, Fletcher G, et al. Building an automated problem list based on natural language processing: lessons learned in the early phase of development. AMIA Annu Symp Proc 2008; 687-691.
47. Li Y, Salmasian H, Harpaz R, et al. Determining the reasons for medication prescriptions in the EHR using knowledge and natural language processing. AMIA Annu Symp Proc 2011; 768-776.
48. Burton MM, Simonaitis L, Schadow G. Medication and indication linkage: A practical therapy for the problem list? AMIA Annu Symp Proc 2008; 86-90.
49. UMLS reference manual. National Library of Medicine: Bethesda, 2009. http://www.ncbi.nlm.nih.gov/books/NBK9676/ (accessed on 25 August 2012).
50. Friedman C. Towards a comprehensive medical language processing system: methods and issues. Proc AMIA Annu Fall Symp 1997; 595-599.
51. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
52. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma 1998; 44: 527-533.
53. Meystre SM, Thibault J, Shen S, et al. Automatically detecting medications and the reason for their prescription in clinical narrative text documents. Stud Health Technol Inform 2010; 160: 944-948.
54. Uzuner O, Solti I, Cadag E. Extracting medication information from clinical text. J Am Med Inform Assoc 2010; 17: 514-518.